Zomig and Urinary incontinence - a phase IV clinical study of FDA data

Summary:

Urinary incontinence is found among people who take Zomig, especially for people who are female, 50-59 old, have been taking the drug for < 1 month.

The phase IV clinical study analyzes which people take Zomig and have Urinary incontinence. It is created by eHealthMe based on reports of 6,500 people who have side effects when taking Zomig from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Feb, 07, 2023

6,500 people reported to have side effects when taking Zomig.
Among them, 22 people (0.34%) have Urinary incontinence.

What is Zomig?

Zomig has active ingredients of zolmitriptan. It is often used in migraine. eHealthMe is studying from 6,941 Zomig users for its effectiveness, alternative drugs and more.

What is Urinary incontinence?

Urinary incontinence (inability to control the flow of urine and involuntary urination) is found to be associated with 2,945 drugs and 2,327 conditions by eHealthMe.

Number of Zomig and Urinary incontinence reports submitted per year:

Time on Zomig when people have Urinary incontinence *:

Gender of people who have Urinary incontinence when taking Zomig *:

female: 85 %
male: 15 %

Age of people who have Urinary incontinence when taking Zomig *:

Common drugs people take besides Zomig *:

Common side effects people have besides Urinary incontinence *:

Urinary Tract Infection: 7 people, 31.82%
Hair Loss: 5 people, 22.73%
Chest Pain: 5 people, 22.73%
Urinary Retention (the inability to completely or partially empty the bladder): 5 people, 22.73%
Drug Ineffective: 4 people, 18.18%
Haematoma (collection of blood outside the blood vessels): 4 people, 18.18%
Stress And Anxiety: 4 people, 18.18%
Muscle Aches (muscle pain): 4 people, 18.18%
Urination - Excessive At Night: 4 people, 18.18%
Depression: 4 people, 18.18%

Common conditions people have *:

Depression: 7 people, 31.82%
Pain: 6 people, 27.27%
Stress And Anxiety: 6 people, 27.27%
Insomnia (sleeplessness): 5 people, 22.73%
Restless Leg Syndrome (a powerful urge to move your legs): 3 people, 13.64%
Nervous System Disorder (a general class of medical conditions affecting the nervous system): 3 people, 13.64%
Musculoskeletal Pain (pain affects the bones, muscles, ligaments, tendons, and nerves): 2 people, 9.09%
Headache (pain in head): 2 people, 9.09%
Endometriosis (appearance of endometrial tissue outside the uterus and causing pelvic pain): 2 people, 9.09%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Zomig and have Urinary incontinence?

Check whether Urinary incontinence is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Urinary incontinence and when was it recovered:

Urinary incontinence in Zomig

Expand to all the drugs that have ingredients of zolmitriptan:

Urinary incontinence and drugs with ingredients of zolmitriptan (33 reports)

Alternative drugs to, pros and cons of Zomig:

Zomig (6,941 reports)

Common Zomig side effects:

Migraine (headache): 1,077 reports
Headache (pain in head): 723 reports
Drug ineffective: 525 reports
Pain: 457 reports
Fatigue (feeling of tiredness): 418 reports
Nausea and vomiting: 384 reports

Browse all side effects of Zomig:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Urinary incontinence treatments and more:

Urinary incontinence (45,206 reports)

COVID vaccines that are related to Urinary incontinence:

Common drugs associated with Urinary incontinence:

All the drugs that are associated with Urinary incontinence:

Urinary incontinence (2,945 drugs)

Common conditions associated with Urinary incontinence:

All the conditions that are associated with Urinary incontinence:

Urinary incontinence (2,327 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on zolmitriptan (the active ingredients of Zomig) and Zomig (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.